Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 1,993 Cr.
- Current Price ₹ 615
- High / Low ₹ 789 / 440
- Stock P/E 34.9
- Book Value ₹ 234
- Dividend Yield 0.45 %
- ROCE 11.7 %
- ROE 8.71 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 2.63 times its book value
- Promoter holding has decreased over last quarter: -0.77%
- Promoter holding is low: 27.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|
39 | 61 | 455 | 487 | 587 | |
30 | 42 | 324 | 365 | 452 | |
Operating Profit | 9 | 19 | 132 | 122 | 135 |
OPM % | 23% | 31% | 29% | 25% | 23% |
3 | 2 | 15 | 19 | 18 | |
Interest | 9 | 9 | 18 | 8 | 11 |
Depreciation | 6 | 12 | 41 | 54 | 71 |
Profit before tax | -3 | 0 | 87 | 80 | 71 |
Tax % | -49% | 180% | 21% | 23% | |
-5 | -0 | 68 | 62 | 57 | |
EPS in Rs | -9.53 | -0.14 | 21.78 | 19.78 | 18.05 |
Dividend Payout % | -0% | -0% | 11% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -7% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 38% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|
Equity Capital | 5 | 5 | 16 | 16 | 16 |
Reserves | 6 | 6 | 669 | 723 | 740 |
Preference Capital | 50 | 65 | -0 | -0 | |
81 | 37 | 41 | 32 | 109 | |
94 | 145 | 150 | 137 | 213 | |
Total Liabilities | 186 | 192 | 875 | 908 | 1,077 |
74 | 131 | 386 | 471 | 559 | |
CWIP | 20 | 6 | 28 | 25 | 28 |
Investments | 1 | 1 | 0 | 0 | 0 |
91 | 55 | 461 | 412 | 491 | |
Total Assets | 186 | 192 | 875 | 908 | 1,077 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|
-23 | 64 | 128 | 76 | |
-47 | -54 | -241 | -109 | |
105 | -41 | 176 | -33 | |
Net Cash Flow | 36 | -31 | 64 | -66 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|
Debtor Days | 79 | 84 | 46 | 55 |
Inventory Days | 21 | 24 | ||
Days Payable | 76 | 100 | ||
Cash Conversion Cycle | 24 | 8 | 46 | 55 |
Working Capital Days | -69 | -113 | -17 | 19 |
ROCE % | 7% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5h - -Analyst / Institutional Investor Meeting scheduled to be held on March 29, 2024.
- Closure of Trading Window 1d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Mar - -Analyst / Institutional Investor Meeting scheduled to be held on March 27, 2024.
-
Intimation For Receipt Of Certificate Of Accreditation.
14 Mar - Company has received a Certificate of Accreditation from College of American Pathologists.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 14 Mar
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Fastest-growing Diagnostic Center
Krsnaa is one of the fastest-growing diagnostic service providers in the country. [1] Krsnaa has expanded its geographical presence from 50+ centers in FY17 to over 2,000+ centers in FY22. [2] The co. has an extensive network of integrated diagnostic centers across India primarily in non-metro and lower-tier cities and towns. As of FY22, the company-operated diagnostic centers offering radiology and pathology services in 14+ states across India. [3]